Mark Lupher's Insider Trades & SAST Disclosures

Mark Lupher's most recent trade in Adverum Biotechnologies Inc was a trade of 10,520 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 17, 2024.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Adverum Biotechnologies Inc
Mark Lupher Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2024 10,520 10,520 - - Stock Option (Right to Buy)
Adverum Biotechnologies Inc
Mark Lupher Director Purchase of securities on an exchange or from another person at price $ 1.35 per share. 07 Feb 2024 130,000 130,000 (0%) 0% 1.4 175,500 Common Stock
Adverum Biotechnologies Inc
Mark Lupher Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2023 40,000 40,000 - - Stock Option (Right to Buy)
Adverum Biotechnologies Inc
Mark Lupher Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2022 40,000 40,000 - - Stock Option (Right to Buy)
Adverum Biotechnologies Inc
Mark Lupher Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jun 2020 30,000 30,000 - - Stock Option (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades